Navigation Links
ADX10059 in Medical News

Migraine prevention by targeting glutamate receptors?

...raine patients, significantly more patients taking adx10059 than those taking placebo (16.7% vs 4.7%, respecti... p = 0.039) were pain-free two hours after dosing. adx10059 administration yielded better pain improvement tha... In addition, there were trends to superiority for adx10059 over placebo for migraine pain improvement (mild o...
ADX10059 in Medical Technology

Addex Achieves Statistically Significant Outcome in Phase IIa Clinical Trial With ADX10059 in Gastro-Esophageal Reflux Disease

GENEVA, April 17, 2007 /PRNewswire/ -- Addex Pharmaceuticals announced today the successful completion of a Phase IIa proof of concept trial with its lead compound ADX10059 in patients with gastro-esophageal reflux disease (GERD), a highly prevalent condition with a significant unmet medical need....

Addex Reports Positive Results in Phase IIa Clinical Trial With ADX10059 in Migraine

... IIa proof of concept trial with its lead compound adx10059 in patients with migraine. The study achieved its ...improvement of migraine pain at other time points. adx10059 has already recently demonstrated a potential ther...rrently completing a Phase IIa study in anxiety. adx10059 is a potent, selective, negative allosteric modula...
ADX10059 in other areas

Addex: Better Tolerated Formulation of ADX10059 Reduces Acid Reflux ...

Addex: Better Tolerated Formulation of ADX10059 Reduces Acid Reflux. ... ADX10059 is a first-in-class negative allosteric modulator (NAM) of metabotropic ...

Addex Starts A Second Phase IIb Trial Of ADX10059 In GERD

Addex Pharmaceuticals (SWISS: ADXN), the allosteric modulation company, announced the start of a Phase IIb trial of ADX10059 monotherapy in patients with ...

Addex Starts A Phase IIb Trial Of ADX10059 For Migraine Prevention

Addex Pharmaceuticals (SWISS: ADXN), the allosteric modulation company, announced the start of a Phase IIb trial of ADX10059 as a migraine prevention therapy in ...

A proof-of-concept study evaluating the effect of ADX10059, a ...

ADX10059 250 mg tds reduced pH-metry-measured oesophageal acid exposure, ... ADX10059 50 mg tds was not significantly superior to placebo. ADX10059 was ...

A Proof Of Concept Study Evaluating The Effect Of ADX10059, A ...

ADX10059 was generally well tolerated. Conclusion: The mGluR5 NAM ADX10059 ... ADX10059 appears to have a potential role in clinical management of GERD. ...

ADX10059 as a Monotherapy in Patients With Gastroesophageal Reflux ...

Evaluation of the effect of ADX10059 on symptom control in patients with ... Drug: ADX10059 Matching Placebo. oral administration. Eligibility. Ages Eligible ...
Other Tags
(Date:2/27/2015)... The Radiology Business Management Association ... class of Fellows — one of the most highly ... , Since 2009, the RBMA Fellowship program has ... members to the Association and the profession. Fellow of ... Fellow candidate must meet a very high standard for ...
(Date:2/27/2015)... Leading massage chair retailer Emassagechair.com is known ... month they take a look at leading issues and help ... In the month of March they will be recognizing National ... by bringing awareness to the time change that occurs as ... start on March 2nd, and last until March 8th when ...
(Date:2/27/2015)... to a Feb. 12, 2015 news release by Verastem, ... by killing cancer stem cells, has received orphan drug designation ... in the treatment of mesothelioma.* According to the release, orphan ... development of drugs for the treatment of rare diseases. ... Melinda Helbock, Founder of The Law Office of Melinda J. ...
(Date:2/27/2015)... Atlanta, GA (PRWEB) February 27, 2015 ... firm, Martin Ventures, is collaborating with the Atlanta-based ... accelerate the adoption of Jvion’s advanced predictive capabilities ... predictive analytics company that identifies and prevents financial ... growing need for predictions that help prevent patient ...
(Date:2/27/2015)... Santa Cruz, CA (PRWEB) February 27, 2015 ... Opal Gas Processing Plant in Lincoln County, Wyoming. ... the area in preparation for interstate natural gas pipeline ... the natural gas., The Opal plant initially began operations ... expansions to serve growing natural gas production in Wyoming. ...
Breaking Medicine News(10 mins):Health News:RBMA Issues Call for Fellowship Applicants 2Health News:Emassagechair Wants Shoppers to Think About the Benefits of Massage During National Sleep Awareness Week 2Health News:Emassagechair Wants Shoppers to Think About the Benefits of Massage During National Sleep Awareness Week 3Health News:New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma 2Health News:New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma 3Health News:Jvion Gains Strategic Collaboration Partner in Martin Ventures 2Health News:Jvion Gains Strategic Collaboration Partner in Martin Ventures 3Health News:Clean Water Systems Supplies Advanced Chlorine Disinfection Skid for Wyoming Gas Plant 2
(Date:2/12/2015)... Feb. 12, 2015   MedNet Solutions , ... clinical study management systems, has recently bolstered its ... distinguishing iMedNet as the ... (CROs) and healthcare consultants.  Building on the Program,s ... referrals and numerous co-marketing opportunities), MedNet,s new and ...
(Date:2/11/2015)... , February 11, 2015 ... report "Access Control Market by Product (Cards and Readers, ... Military and Defense, Government, Industrial, Healthcare, Education) and By ... by MarketsandMarkets, the Access Control Market is ... growing at a CAGR of 10.6% between ...
(Date:2/9/2015)... 9, 2015  Lintec of America recently announced an ... nanotube (CNT) macrostructures, including sheets, yarns and ribbons, developed ... Leveraging the vast industrial resources of the global ... , Lintec of America is forming the Nano-Science and ... , focusing on scaling up the manufacturing and commercialization ...
Breaking Biology News(10 mins):MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
Other Contents